Science Explorer Back to mapMap

Symphogen (Denmark)

Research works
78
▼ 72% vs 2018-21
Citations
2.6k
32.6 per fractional work
Top-10% rate
10.9%
all institutions 10.0%
Open access
29%
world 40%
International
34%
world 18%

Not ranked overall: Symphogen (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Symphogen (Denmark) work in?

In all years, 57% of research at Symphogen (Denmark) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (57%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (8%). It does 2.3× the world's share of Life Sciences.

Health Sciences: 44 fractional works · 56.6% of its workMedicine: 44 fractional works · 56.6% of its workRadiology, Nuclear Medicine and Imaging: 18 fractional works · 22.9% of its workOncology: 16 fractional works · 19.8% of its workPulmonary and Respiratory Medicine: 3 fractional works · 3.7% of its workHepatology: 2 fractional works · 2.7% of its workEpidemiology: 1 fractional works · 1.2% of its workHematology: 1 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.0% of its workPathology and Forensic Medicine: 1 fractional works · 0.9% of its workInfectious Diseases: 1 fractional works · 0.9% of its workGenetics: 1 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.5% of its workSurgery: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workLife Sciences: 30 fractional works · 38.8% of its workBiochemistry, Genetics and Molecular Biology: 23 fractional works · 29.9% of its workMolecular Biology: 17 fractional works · 21.7% of its workBiotechnology: 3 fractional works · 3.3% of its workGenetics: 1 fractional works · 1.8% of its workCancer Research: 1 fractional works · 1.7% of its workPhysiology: 0 fractional works · 0.5% of its workBiophysics: 0 fractional works · 0.4% of its workEndocrinology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 6 fractional works · 7.8% of its workImmunology: 5 fractional works · 6.6% of its workVirology: 1 fractional works · 1.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.7% of its workAnimal Science and Zoology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workPhysical Sciences: 4 fractional works · 4.6% of its workChemistry: 2 fractional works · 2.4% of its workSpectroscopy: 2 fractional works · 2.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 1 fractional works · 0.9% of its workBiomedical Engineering: 1 fractional works · 0.9% of its workEnvironmental Science: 1 fractional works · 0.7% of its workEcology: 1 fractional works · 0.7% of its workComputer Science: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.0% of its workALL ITS WORKSymphogen(Denmark)78fractional works, all years
Life Sciences39%Physical Sciences5%Health Sciences57%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 12 fields, with their numbers
    1. Medicine4456.6%
    1. Biochemistry, Genetics and Molecular Biology2329.9%
    2. Immunology and Microbiology67.8%
    3. Agricultural and Biological Sciences10.7%
    4. Neuroscience00.3%
    1. Chemistry22.4%
    2. Engineering10.9%
    3. Environmental Science10.7%
    4. Computer Science00.3%
    5. Physics and Astronomy00.2%
    6. Materials Science00.1%
    7. Mathematics00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Symphogen (Denmark)?

Ranked on the quality score, Ivan David Horak, Mikkel Wandahl Pedersen and John Sørensen Haurum lead among researchers whose main affiliation is Symphogen (Denmark).

  1. 1 Ivan David Horak Denmark · #144,630 worldwide 18k citations · 458 works
  2. 2 Mikkel Wandahl Pedersen Denmark · #514,980 worldwide 3.2k citations · 160 works
  3. 3 John Sørensen Haurum Denmark · #674,338 worldwide 2.6k citations · 65 works
  4. 4 Michael Kragh Denmark · #688,224 worldwide 2.6k citations · 184 works
  5. 5 Helle Jane Jacobsen Denmark · #831,207 worldwide 1.4k citations · 62 works
  6. 6 Klaus Koefoed Denmark · #937,440 worldwide 1.9k citations · 70 works
  7. 7 Johan Lantto Denmark · #1,593,991 worldwide 1.6k citations · 119 works
  8. 8 Per‐Johan Meijer Denmark · #1,600,643 worldwide 1.8k citations · 22 works
  9. 9 Dietmar Weilguny Denmark · #1,642,274 worldwide 1.1k citations · 57 works
  10. 10 Thomas T. Poulsen Denmark · #1,677,089 worldwide 903 citations · 116 works
All ranked researchers at Symphogen (Denmark)

What are the most cited papers from Symphogen (Denmark)?

The most cited paper from Symphogen (Denmark) is "Novel antibody–antibiotic conjugate eliminates intracellular S. aureus" (Sophie M. Lehar et al., 2015), with 851 citations. Next come "The genomic landscape of response to EGFR blockade in colorectal cancer" (500) and "Targeting the ERBB family in cancer: couples therapy" (470).

Most cited papers
#PaperReleasedCitations
1 Novel antibody–antibiotic conjugate eliminates intracellular S. aureus Sophie M. Lehar et al. · Nature Nov 2015 851
2 The genomic landscape of response to EGFR blockade in colorectal cancer Andrea Bertotti et al. · Nature Open access 29 Sep 2015 500
3 Targeting the ERBB family in cancer: couples therapy Niall Christopher Tebbutt, Mikkel Wandahl Pedersen, Terrance G. Johns · Nature reviews. Cancer Review 16 Aug 2013 470
4 Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog Hanne Borger Rasmussen, Sven Branner, Finn C. Wiberg et al. · Nature Structural Biology 16 Dec 2002 426
5 NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 Manisha H. Shah et al. · Journal of the National Comprehensive Cancer Network Open access Jun 2018 393
All 60 most cited papers, with filters and sorting

Which keywords describe research at Symphogen (Denmark)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Chemotherapy, Monoclonal Antibody and Breast Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation22▲ 124×3 topics
  2. Monoclonal Antibodies21▲ 184×3 topics
  3. Therapeutic Antibodies20▲ 202×2 topics
  4. Antibody Engineering15▲ 196×1 topic
  5. Fc Receptors15▲ 196×1 topic
  6. Chemotherapy11▲ 20×6 topics
  7. Monoclonal Antibody11▲ 198×2 topics
  8. Breast Cancer8▲ 37×1 topic
  9. HER28▲ 341×1 topic
  10. Biopharmaceuticals7▲ 124×3 topics
  11. Recombinant Proteins6▲ 152×2 topics
  12. Targeted Therapy6▲ 38×5 topics
  13. Immunogenicity5▲ 132×2 topics
  14. Cancer5▲ 4.7×7 topics
  15. Protein Aggregation5▲ 82×1 topic
  16. Stability5▲ 34×1 topic
  17. Tumor Microenvironment4▲ 16×6 topics
  18. PET Imaging4▲ 24×3 topics
  19. Angiogenesis4▲ 12×4 topics
  20. Inflammation4▲ 2.0×8 topics
  21. Glycans4▲ 54×1 topic
  22. Immune System4▲ 14×1 topic
  23. Immunotherapy3▲ 6.6×7 topics
  24. Clinical Trials3▲ 6.4×4 topics
  25. ALK Inhibitors3▲ 68×1 topic
  26. EGFR Mutations3▲ 68×1 topic
  27. Mammalian Cells3▲ 87×1 topic
  28. Recombinant Protein3▲ 87×1 topic
  29. Radioimmunotherapy2▲ 80×1 topic
  30. Radiopharmaceuticals2▲ 80×1 topic
  31. Autoimmunity2▲ 15×2 topics
  32. Cetuximab2▲ 35×2 topics
  33. Gene Therapy2▲ 11×3 topics
  34. Molecular Subtypes2▲ 34×2 topics
  35. Tumor Regression2▲ 33×2 topics
  36. Fluorouracil2▲ 86×1 topic
  37. KRAS Mutations2▲ 86×1 topic
  38. Macrophages2▲ 15×2 topics
  39. Cancer Immunotherapy2▲ 18×2 topics
  40. Foxp32▲ 31×1 topic

Which research topics does Symphogen (Denmark) publish most on?

By volume in 2022-now: Protein purification and stability, Advanced Proteomics Techniques and Applications, Viral Infectious Diseases and Gene Expression in Insects and Monoclonal and Polyclonal Antibodies Research.

  1. 1 Protein purification and stability Molecular Biology 1 works
  2. 2 Advanced Proteomics Techniques and Applications Spectroscopy 1 works
  3. 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Mass Spectrometry Techniques and Applications Spectroscopy 0 works
  6. 6 HER2/EGFR in Cancer Research Oncology 0 works
  7. 7 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 0 works
  9. 9 CAR-T cell therapy research Oncology 0 works
  10. 10 Vascular Malformations and Hemangiomas Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.7%not open71.3%

World: 40% of research is openly available.

with international co-authors34.3%domestic only65.7%

World: 18% is written across borders.

How has Symphogen (Denmark)'s research output changed?

Output in 2022-2025 was 72% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Symphogen (Denmark) as a percentage of every work published that year, 0.0000018% in 2024.

still counting0.00020%0.00040%Symphogen (Denmark)0.0000024% in 202520102020

Fractional works of Symphogen (Denmark) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Ballerup Municipality

All research institutions in Ballerup Municipality

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Symphogen (Denmark). Posts are plain text and can be reported.